Tonsillectomy and immunosuppression improve outcomes in Caucasians with high-risk IgA nephropathy
Nephrology Dialysis Transplantation · 2025
DOI: 10.1093/ndt/gfaf262 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Zinaida S Kochoyan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Research Institute of Nephrology, Pavlov University, Saint Petersburg, Russian Federation. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Immunosuppression Therapy, Immunosuppressive Agents, Tonsillectomy. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Russian Foundation for Scientific Research.
Abstract (Originalsprache)
Background
Considering the absence of such data, this study explored the effectiveness of immunosuppressive therapy (IST) and tonsillectomy (TE) in Caucasians with high-risk immunoglobulin A nephropathy (IgAN).
Methods
The prospective non-randomised comparative study enrolled incident Caucasian patients with a definite clinical and histological diagnosis of primary IgAN (n = 221, age 35 ± 11 years, 52% male) at high risk of progression. All patients received IST (72.3% glucocorticoid monotherapy) without TE (control group, n = 136) or with TE (TE + IST; experimental group, n = 85). The median follow-up period was 33 months (interquartile range 15–69). Kaplan–Meier and Cox regression analyses combined with pseudo-randomisation methods (1:1 matching of comparison groups) and inverse probability of treatment weighting (IPTW) were applied to assess the effects of TE + IST on primary outcomes: complete remission (CR), overall (complete or partial) remission (OR) and disease progression (>40% decrease in estimated glomerular filtration rate or end-stage kidney disease).
Results
The rates of early OR in the IST and TE + IST groups were 72.6% and 95.2%, respectively (P < .001). In the Kaplan–Meier analyses, the time to remission was 2-fold shorter in the TE + IST group (P < .001). In the adjusted Cox models, the probabilities of early OR and CR were significantly higher in the tonsillectomy group compared with IST alone {hazard ratio [HR] 3.364 [95% confidence interval (CI) 2.302–4.917] and HR 6.315 [95% CI 2.620–15.224], respectively}. The disease progression was registered in 3 patients (3.5%) in those on the combination therapy compared with 39 patients (28.9%) in the IST group [adjusted HR 0.126 (95% CI 0.037–0.427)]. Analyses performed in propensity score 1:1 matched groups and IPTW Cox models yielded similar results.
Conclusions
Tonsillectomy and immunosuppressive therapy may be effective for remission induction and delaying progression in high-risk IgAN patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Research Institute of Nephrology, Pavlov University, Saint Petersburg, Russian Federation.
ORCID-Profile: Zinaida S Kochoyan, Vladimir A Dobronravov
Förderung
- Russian Foundation for Scientific Research
Zitieren
APA
Kochoyan, Z. S., & Dobronravov, V. A. (2025). Tonsillectomy and immunosuppression improve outcomes in Caucasians with high-risk IgA nephropathy. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf262
Vancouver
Kochoyan ZS, Dobronravov VA. Tonsillectomy and immunosuppression improve outcomes in Caucasians with high-risk IgA nephropathy. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf262
BibTeX
@article{Kochoyan2025,
author = {Kochoyan, Zinaida S and Dobronravov, Vladimir A},
title = {Tonsillectomy and immunosuppression improve outcomes in Caucasians with high-risk IgA nephropathy},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
doi = {10.1093/ndt/gfaf262}
}
EUVIMED